Tag: erythropoietin (epo) industry

  • Comprehensive Erythropoietin (EPO) Market Analysis 2024: Size, Share, And Key Trends

    Comprehensive Erythropoietin (EPO) Market Analysis 2024: Size, Share, And Key Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What Growth Rate Can Be Expected in the Erythropoietin (EPO) Market from 2024 Through 2033?

    The market for erythropoietin (epo) has experienced significant expansion in the recent past. The market is set to increase from $17.29 billion in 2023 to $19.25 billion in 2024, exhibiting a compound annual growth rate (CAGR) of 11.4%. The growth seen in the historic period can be linked to factors such as improved patient education and awareness, consolidation in the pharmaceutical industry, changes in healthcare reimbursement policies, market expansion, increased demand, as well as the expiration of patents and the introduction of biosimilars.

    In the near future, the erythropoietin (epo) market is projected to witness exponential growth. Predicted to reach $30.92 billion in 2028, the market’s compound annual growth rate (CAGR) is forecast at 12.6%. Factors contributing to this upward swing in coming years could include market competition and effects of biosimilarity, disease prevalence forecasts, modifications in healthcare policies and reimbursements, growth in developing markets, and increased emphasis on clinical trials and research. The forecast period is likely to observe major trends such as supply management improvements, global market expansion, enhancement of patient education and awareness, changes in reimbursement policies, market consolidation, and mergers.

    Claim Your Free Sample of the Global Erythropoietin (EPO) Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3436&type=smp

    What Dynamics Are Shaping the Growth of the erythropoietin (epo) Market?

    The anticipated surge in the erythropoietin market is primarily due to the increasing number of chronic kidney disease cases. Erythropoietin, which assists in the creation of red blood cells to boost immunity, is required in dealing with these growing cases. As per a report by the Centers for Disease Control and Prevention, published in March 2021, it was estimated that 15% of US adults, equating to 37 million people, were afflicted with chronic kidney disease (CKD). Those aged 65 or older were more predisposed to CKD (38%), followed by the age bracket 45-64 (13%), and then those aged 18-44 (7%). Anemia is a common consequence of chronic kidney diseases, amplifying the requirement for erythropoietin to mitigate the effects, thereby pushing the market revenues upwards.

    What Are the Essential Segments of the Erythropoietin (EPO) Market?

    1) By Product: Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Other Products

    2) By Drug Class: Biologist, Biosimilar

    3) By Application: Cancer, Hematology, Renal diseases, Neurology, Other Applications

    What Are the Defining Trends in the Evolving Erythropoietin (EPO) Market?

    In the erythropoietin market, leading businesses are marking their place through the innovation of products like Varenzin-CA1. This drug, a molidustat oral suspension, has been conditionally approved by the FDA for managing nonregenerative anemia resulting from chronic kidney disease (CKD) in cats. Elanco, an American pharmaceutical company, received FDA approval for Varenzin-CA1 in May 2023. The drug is specifically designed for cats and has a unique mechanism that triggers the genetic transcription of erythropoietin (EPO), thus amplifying both EPO and red blood cell production in the cat’s system. Varenzin-CA1 not only provides a convenient at-home solution but also establishes a new standard of care for cats affected by nonregenerative anemia due to CKD.

    Order Now for Fast Delivery of Your Erythropoietin (EPO) Market Report!

    https://www.thebusinessresearchcompany.com/report/erythropoietins-global-market-report

    Which Regions Are Emerging as Leaders in the Erythropoietin (EPO) Market?

    North America was the largest region in the erythropoietin (EPO) market in 2023. The Middle East is expected to be the fastest growing region in the global erythropoietin (EPO) market analysis in the forecast period. The regions covered in the erythropoietin (epo) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Erythropoietin (EPO) Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the erythropoietin (epo) market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Erythropoietin (EPO) Market Include

    1. Erythropoietin (EPO) Market Executive Summary

    2. Erythropoietin (EPO) Market Segments

    3. Erythropoietin (EPO) Market Size And Template Market Growth Rate

    4. Key Erythropoietin (EPO) Market Trends

    5. Major Erythropoietin (EPO) Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Erythropoietin (EPO) Market

    26. Top Erythropoietin (EPO) Companies

    27. Erythropoietin (EPO) Market Opportunities And Strategies

    28. Erythropoietin (EPO) Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Hematology Analyzers and Reagents Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

    Proteomics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/proteomics-global-market-report

    Protein Inhibitors Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/protein-inhibitor-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Takeaways From The Global Erythropoietin (EPO) Market Forecast 2024

    Key Takeaways From The Global Erythropoietin (EPO) Market Forecast 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Erythropoietin (EPO) Global Market Report 2024, the erythropoietin (EPO) market is expected to show significant growth in the forecast period.

    The erythropoietin (EPO) market has experienced rapid growth in recent years and shows promising future prospects. With significant increases in market size and advancements in pharmaceutical research, this blog explores the factors driving this growth, future projections, and major trends that will shape the EPO market.

    Recent Market Growth

    Market Size and Growth Rate

    • 2023 Market Size: $17.29 billion
    • 2024 Market Size: $19.25 billion
    • CAGR (2023-2024): 11.4%

    Historical Growth Drivers

    • Patient Education and Awareness: Increased awareness about EPO treatments and their benefits.
    • Pharmaceutical Industry Consolidation: Mergers and acquisitions enhancing market capabilities.
    • Healthcare Reimbursement Policies: Improved reimbursement policies supporting EPO treatments.
    • Market Expansion and Demand Growth: Rising global demand for effective anemia treatments.
    • Patent Expiration and Biosimilar Entry: Introduction of biosimilars boosting market competition.

    View More On The Erythropoietin (EPO) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/erythropoietins-global-market-report

    Future Market Prospects

    Projected Growth

    • 2028 Market Size: $30.92 billion
    • CAGR (2024-2028): 12.6%

    Future Growth Drivers

    • Market Competition and Biosimilar Impact: Increased competition driving innovation and affordability.
    • Disease Prevalence Projections: Higher incidence of diseases requiring EPO treatments.
    • Healthcare Policy and Reimbursement Changes: Favorable policies enhancing market access.
    • Emerging Markets Growth: Expansion in developing regions boosting overall market size.
    • Clinical Trials and Research Focus: Ongoing research leading to new applications and treatments.

    Major Trends Shaping the Future

    Supply Chain Management

    • Improvements in supply chain efficiency ensuring timely delivery of EPO products.

    Global Expansion and Emerging Markets

    • Entry into new geographic regions and markets driving overall growth.

    Patient Education and Awareness

    • Continued efforts to educate patients on the benefits and availability of EPO treatments.

    Reimbursement Policies

    • Enhanced policies improving patient access to EPO therapies.

    Market Consolidation and Mergers

    • Ongoing mergers and acquisitions fostering market stability and growth.

    Rising Incidence of Chronic Kidney Diseases

    Impact on EPO Market

    • Chronic Kidney Disease (CKD) Incidence: Significant driver for EPO demand.
    • CDC Report (2021): 15% of U.S. adults, or 37 million people, estimated to have CKD.
    • Age Distribution: Higher CKD prevalence in older adults (38% in 65+ age group).

    EPO in CKD Treatment

    • EPO Role: Used to stimulate red blood cell production in CKD patients, addressing anemia and improving immunity.

    Key Players in the EPO Market

    • Associated British Foods PLC
    • DuPont de Nemours Inc.
    • Kerry Group PLC
    • Firmenich SA
    • Koninklijke DSM NV
    • Dyadic International Inc.
    • Novozymes A/S
    • Endo International PLC
    • Chr Hansen Holding A/S
    • Advanced Enzyme Technologies Ltd.
    • Catalyst Pharmaceuticals Inc.
    • Codexis Inc.
    • AB Enzymes GmbH
    • Brain Biotech AG
    • Sunson Industry Group Co. Ltd.

    Innovations in Erythropoietin Market

    Wanbang’s Yi Bao Breakthrough

    • Product: Yi Bao (Human Erythropoietin for Injection)
    • Approval: National Medical Products Administration (NMPA) approval in September 2021.
    • Application: Treatment of anemia caused by chemotherapy in non-myeloid malignancies.

    Market Segmentation

    By Product

    • Epoetin-alfa
    • Epoetin-beta
    • Darbepoetin-alfa
    • Other Products

    By Drug Class

    • Biologics
    • Biosimilars

    By Application

    • Cancer
    • Hematology
    • Renal Diseases
    • Neurology
    • Other Applications

    Regional Insights

    • Largest Market: North America
    • Fastest Growing Region: Middle East (forecast period)

    Conclusion

    The erythropoietin market is set for substantial growth, driven by rising disease prevalence, advancements in healthcare policies, and increased competition from biosimilars. With continuous innovations and expanding global reach, the EPO market is poised to deliver significant benefits to patients worldwide, particularly those suffering from chronic kidney diseases and other related conditions.

    Request A Sample Of The Global Erythropoietin (EPO) Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=3436&type=smp